Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

Clin Case Rep. 2022 Jan 7;10(1):e05209. doi: 10.1002/ccr3.5209. eCollection 2022 Jan.

Abstract

Chimeric antigen receptor (CAR) T cell-related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria is essential, and the combination of several techniques for CAR T-cell follow-up, allows a more precise management of this complication.

Keywords: CAR T cells; hemophagocytic lymphohistiocytosis; macrophage activation syndrome; tisagenlecleucel.

Publication types

  • Case Reports